Latest Patents

Patents imply intellectual property and it has a $ value that can be associated depending on the field and type of patent that is allocated. Patents also increase the enterprise value of the company and help prevent copy-cats from copying the idea without having royalt payments or licencing deals. We like it when companies get patents awarded!. To protect IP companies aggressively file provisional patents even before they have a working product. The below table provides a way to look at what has been done by companies and use this as a factor to make investment decisions.

     
Title Filing Date Publication Date Grant Date
CRISPR hybrid DNA/RNA polynucleotides and methods of use 2023-4-04 2023-5-18 2023-5-18
A method of capturing crispr endonuclease cleavage products 2022-12-05 2023-6-15
Exonuclease-coupled real-time endonuclease activity assay 2022-10-24 2023-5-04
Humanized BCMA antibody and BCMA-CAR-T cells 2022-8-17 2022-11-01
Methods and materials for treating cancer using car constructs with an … 2022-6-14 2022-12-22
Novel crispr-associated (cas) protein 2022-2-23 2022-6-09
Engineered cascade components and cascade complexes 2022-2-11 2022-3-03
DNA-containing polynucleotides and guides for CRISPR V-type systems and methods … 2021-10-18 2023-7-28
Dna-containing polynucleotides and guides for crispr type v systems, and … 2021-10-18 2023-8-23
Compositions and methods of nucleic acid-targeting nucleic acids 2021-8-20 2022-9-08
Modified cascade ribonucleoproteins and uses thereof 2021-2-18 2021-6-10
Engineered cascade components and cascade complexes 2020-12-11 2021-4-08
Crispr abasic restricted nucleotides and crispr accuracy via analogs 2020-12-08 2021-6-17
Engineered Cascade Components and Cascade Complexes 2020-9-21 2021-1-07
Engineered nucleic-acid targeting nucleic acids 2020-6-19 2022-1-18 2022-1-18
Engineered nucleic acid-targeting nucleic acids 2020-3-11 2021-5-11 2021-5-11
Plasmids for gene editing 2020-2-24 2022-9-15
Engineered nucleic-acid targeting nucleic acids 2019-10-07 2019-10-24
Suicide module compositions and methods 2019-9-30 2021-7-15
Engineered cascade components and cascade complexes 2019-6-12
Engineered nucleic acid-targeting nucleic acids 2019-3-04 2019-9-12
Engineered gut microbes and uses thereof 2019-2-04 2021-4-01
Modified lymphocytes 2018-12-04 2019-6-13
Engineered crispr-cas9 compositions and methods of use 2018-5-17 2019-8-16
Methods for increasing cas9-mediated engineering efficiency 2018-2-02 2018-6-21
Methods of modifying a target nucleic acid with an Argonaute 2017-12-21 2018-11-13 2018-11-13
Protein engineering methods 2017-8-11 2018-2-15
Methods for modulating dna repair outcomes 2017-2-21 2019-8-21 2019-8-21
RNA Modification to Engineer Cas9 Activity 2016-12-26 2017-4-27
Directed nucleic acid repair 2016-8-31 2017-3-09
Crispr-cas compositions and methods 2016-6-10 2016-12-15
Crispr hybrid dna/rna polynucleotides and methods of use 2016-1-27 2023-8-29 2023-8-29
Rna modification to engineer cas9 activity 2015-6-24 2015-12-30
Polynucleotides adn/arn crispr hybrides et leurs procedes d'utilisation 2016-1-27 2023-8-29 2023-8-29